Researchers recently looked at differences in survival time between patients with grade II and grade III spinal meningioma.
For the first time, researchers have isolated a subtype of gamma-delta T-cells that offers protection in women with triple-negative breast cancer.
Why are geriatric patients less likely to get treated for their non-melanoma skin cancers? Researchers investigate and report.
After conflicting opinions over the years, a study published in the journal Hematology explores the association between diabetes mellitus non-hodgkin lymphoma.
There could be a new way to diagnose brain tumors earlier.
Researchers report on the BRIGHT AML 1019 Phase III trial.
Researchers explore the predictive capability of EVI1 expression.
A pooled analysis of safety, efficacy of pembrolizumab in patients 75+ years of age with PD-L1+ NSCLC
A study showed patients seem to lack an understanding of the meaning of progression-free survival.
The neoantigens found in the patients’ tumors (non-small-cell lung cancer) which were highly dissimilar were enriched for hydrophobic sequences, and correlated with survival rates after the PD-1 checkpoint therapy.